SK67295A3 - Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them - Google Patents

Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them Download PDF

Info

Publication number
SK67295A3
SK67295A3 SK672-95A SK67295A SK67295A3 SK 67295 A3 SK67295 A3 SK 67295A3 SK 67295 A SK67295 A SK 67295A SK 67295 A3 SK67295 A3 SK 67295A3
Authority
SK
Slovakia
Prior art keywords
group
formula
compound
carbon atoms
amino
Prior art date
Application number
SK672-95A
Other languages
English (en)
Slovak (sk)
Inventor
Stefan Bengtsson
Sven Hellberg
Nina Mohell
Lian Zhang
Gerd Hallnemo
David Jackson
Bengt Ulff
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK67295A3 publication Critical patent/SK67295A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
SK672-95A 1993-10-07 1994-09-16 Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them SK67295A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303274A SE9303274D0 (sv) 1993-10-07 1993-10-07 Novel phenylethyl and phenylproplamines
PCT/SE1994/000860 WO1995009835A1 (en) 1993-10-07 1994-09-16 Novel phenylethyl and phenylpropylamines

Publications (1)

Publication Number Publication Date
SK67295A3 true SK67295A3 (en) 1996-09-04

Family

ID=20391336

Family Applications (1)

Application Number Title Priority Date Filing Date
SK672-95A SK67295A3 (en) 1993-10-07 1994-09-16 Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them

Country Status (31)

Country Link
US (1) US5693630A (zh)
EP (1) EP0672032B1 (zh)
JP (1) JPH08504835A (zh)
KR (1) KR950704236A (zh)
CN (1) CN1048718C (zh)
AT (1) ATE161823T1 (zh)
AU (1) AU680303B2 (zh)
BR (1) BR9405632A (zh)
CA (1) CA2150005A1 (zh)
CZ (1) CZ148595A3 (zh)
DE (1) DE69407751T2 (zh)
DK (1) DK0672032T3 (zh)
EE (1) EE03214B1 (zh)
ES (1) ES2111959T3 (zh)
FI (1) FI952772A (zh)
GR (1) GR3026484T3 (zh)
HU (1) HUT73774A (zh)
IL (1) IL111133A (zh)
IS (1) IS4204A (zh)
LT (1) LT3920B (zh)
LV (1) LV10862B (zh)
NO (1) NO305947B1 (zh)
NZ (1) NZ274273A (zh)
PL (1) PL179011B1 (zh)
RU (1) RU2133735C1 (zh)
SE (1) SE9303274D0 (zh)
SI (1) SI9420007A (zh)
SK (1) SK67295A3 (zh)
TW (1) TW338036B (zh)
WO (1) WO1995009835A1 (zh)
ZA (1) ZA947209B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152701A0 (en) * 2000-05-25 2003-06-24 Hoffmann La Roche Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
MXPA04002304A (es) * 2001-09-12 2004-06-29 Merck Patent Gmbh Uso de aminometil cromanos sustituidos en el tratamiento de trastornos de movimiento.
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
IL157751A0 (en) 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
IL156203A0 (en) * 2003-05-29 2003-12-23 Yissum Res Dev Co Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7644E (fr) 1903-08-11 1907-09-17 Chappee Et Fils Soc Nouveau système d'assainissement des villes
DE1518375A1 (de) * 1965-06-08 1969-08-14 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 2-Amino-halogenbenzylaminen
FR7644M (zh) * 1968-06-24 1970-02-02
DE2345423A1 (de) * 1973-09-08 1975-03-20 Thomae Gmbh Dr K Neue substituierte phenylaethylaminderivate, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu deren herstellung
US4021558A (en) * 1973-09-08 1977-05-03 Boehringer Ingelheim Gmbh 1,3-Dioxo-2-[(methoxyphenethyl-amino)-alkyl]-4,4-dimethyl-isoquinolines and salts thereof useful as hypotensive agents
AT330777B (de) * 1973-09-08 1976-07-26 Thomae Gmbh Dr K Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
JPS5414956A (en) * 1977-07-04 1979-02-03 Sumitomo Chem Co Ltd Novel 3-amino-4-homoisotwistan derivative
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
FR2608157B1 (fr) * 1986-12-11 1989-09-08 Roussel Uclaf Nouveaux derives de l'azaspirodecane, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant et intermediaires
EP0274674B1 (fr) 1986-12-12 1991-05-08 Sediver, Societe Europeenne D'isolateurs En Verre Et Composite Procédé de fabrication d'un parafoudre et parafoudre obtenu par ce procédé

Also Published As

Publication number Publication date
GR3026484T3 (en) 1998-06-30
NO305947B1 (no) 1999-08-23
EP0672032B1 (en) 1998-01-07
IS4204A (is) 1995-04-08
US5693630A (en) 1997-12-02
ZA947209B (en) 1995-07-07
SI9420007A (en) 1996-04-30
JPH08504835A (ja) 1996-05-28
LT95059A (en) 1995-10-25
CN1048718C (zh) 2000-01-26
IL111133A0 (en) 1994-12-29
FI952772A0 (fi) 1995-06-06
CN1115575A (zh) 1996-01-24
BR9405632A (pt) 1999-05-25
DE69407751T2 (de) 1998-04-16
DE69407751D1 (de) 1998-02-12
FI952772A (fi) 1995-06-06
PL309189A1 (en) 1995-09-18
PL179011B1 (pl) 2000-07-31
RU2133735C1 (ru) 1999-07-27
CZ148595A3 (en) 1996-01-17
EP0672032A1 (en) 1995-09-20
ATE161823T1 (de) 1998-01-15
DK0672032T3 (da) 1998-05-04
NO952232L (no) 1995-07-18
ES2111959T3 (es) 1998-03-16
IL111133A (en) 1998-12-27
LV10862A (lv) 1995-10-20
LT3920B (en) 1996-04-25
SE9303274D0 (sv) 1993-10-07
HUT73774A (en) 1996-09-30
WO1995009835A1 (en) 1995-04-13
NZ274273A (en) 1996-10-28
TW338036B (en) 1998-08-11
RU95112451A (ru) 1997-04-20
EE03214B1 (et) 1999-08-16
KR950704236A (ko) 1995-11-17
LV10862B (en) 1996-08-20
AU680303B2 (en) 1997-07-24
NO952232D0 (no) 1995-06-06
AU7825694A (en) 1995-05-01
CA2150005A1 (en) 1995-04-13
HU9501643D0 (en) 1995-08-28

Similar Documents

Publication Publication Date Title
KR0179661B1 (ko) N-페닐알킬 치환된 알파-아미노 카복스아미드 유도체 및 이를 포함하는 약제학적 조성물 및 이의 제조방법
EP0447285B1 (fr) Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP1613597B1 (en) 6-substituted nicotinamide derivatives as opioid receptor antagonists
US6172091B1 (en) 1,2-Disubstituted cyclopropanes
FR2676055A1 (fr) Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
MXPA03009083A (es) Tiohidantoinas y su utilizacion en el tratamiento de diabetes.
JPH07316113A (ja) 新規アリールアルキル（チオ）アミド化合物
NL1025933C2 (nl) 4-Fenyl-piperidineverbindingen en de toepassing ervan als modulatoren van opioïde receptoren.
NZ551509A (en) Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
DE60018194T2 (de) Hydroxamsäurederivate, verfahren zu ihrer herstellung und medikamente die diese als aktiven wirkstoff enthalten
SK67295A3 (en) Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them
JPS6323856A (ja) カルバミン酸または尿素の誘導体、その製造法およびその医薬への応用
PL108466B1 (en) Method of producing cis 4a-arylooctahydro-1h-2-pyrindins
CA2025731A1 (en) Phenylalkyl amine derivatives having antiischaemic activity
TW318843B (zh)
JPS6039069B2 (ja) アミン誘導体
CA2104626A1 (en) Pharmaceutical compounds
FR2514353A2 (fr) Derives de piperidine et leur application en therapeutique
AU2003279276A1 (en) Preparation of triazospiro compounds
SK2002001A3 (en) New 4-amino-1-aryl-pyridine-2-ones with anticonvulsive action and method for producing same
ES2223824T3 (es) Benzoxazinas para usar en el tratamiento de la enfermedad de parkison.
SK166495A3 (en) Pharmacologically effective enantiomers, preparation method threof, intermediate products of this method and use
MXPA01003846A (en) 1,2-disubstituted cyclopropanes
FR2669928A1 (fr) Nouveaux derives de pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
CH447171A (fr) Procédé de préparation de nouveaux dérivés du 5-amino-méthyl-4,5,6,7-tétrahydro-4-oxo-indole